CTNM
Contineum Therapeutics, Inc.
13.10$
+1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| -1.05 | -0.80 | 0.77 | -1.27 | -2.00 | |
| 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| 0.07 | 0.08 | 0.09 | 0.26 | 0.36 | |
| 0.00 | -0.05 | -0.04 | 0.21 | -0.22 | |
| 0.01 | 0.00 | 0.02 | 0.02 | 0.01 | |
| -2.59 | 0.89 | -2.61 | -2.70 | -0.13 | |
| 0.00 | 0.00 | 0.00 | 0.00 | – | |
| 0.00 | -0.05 | -0.15 | 0.00 | – | |
| 3.18 | -0.05 | 2.24 | 4.22 | 4.07 | |
| -0.45 | 0.04 | 0.40 | 0.25 | 1.94 | |
| -1.05 | -0.81 | 0.75 | -1.29 | -2.01 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.